Edoxaban Impurity H
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

1255529-28-2Edoxaban Impurity H

● In Stock

Catalogue No.:VE008118
CAS No.:1255529-28-2
Mol. Formula:C24H30ClN7O4S
Mol. Weight:548.06 g/mol

Additional information on CAS 1255529-28-2

Parent drug

Edoxaban

IUPAC Name

N-(5-Chloropyridin-2-yl)-N’-[(1S, 2S, 4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4, 5, 6, 7-tetrahydrothiazolo[5, 4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide

Pharmacopoeial Synonyms

N/A

Other Synonyms

Edoxaban (SSR)-Isomer; 2,4-diepi-Edoxaban

Smiles

O=C(N[C@H]1C[C@@H](CC[C@@H]1NC(C(NC2=CC=C(C=N2)Cl)=O)=O)C(N(C)C)=O)C3=NC4=C(S3)CN(C)CC4

InChI

InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15+,17+/m1/s1

Description

Edoxaban Impurity H is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Edoxaban.

References

Cuker, Adam, and Holleh Husseinzadeh. “Laboratory Measurement of the Anticoagulant Activity of Edoxaban: A Systematic Review.” Journal of Thrombosis and Thrombolysis, vol. 39, no. 3, Feb. 2015, pp. 288–94, https://doi.org/10.1007/s11239-015-1185-7. ‌Camm, A. John, and Henri Bounameaux. “Edoxaban.” Drugs, vol. 71, no. 12, Aug. 2011, pp. 1503–26, https://doi.org/10.2165/11595540-000000000-00000.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url